SC 13G Filing

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

May 19, 2017

Accession Number

0000935836-17-000264

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →